Sypl1-flox Mouse
一般名
Sypl1-flox
製品ID
S-CKO-04403
背景情報
C57BL/6JCya
系統ID
CKOCMP-19027-Sypl1-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Sypl1-flox Mouse(カタログ番号S-CKO-04403)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Sypl1-flox
系統ID
CKOCMP-19027-Sypl1-B6J-VA
遺伝子名
製品ID
S-CKO-04403
遺伝子別名
PanI, Pphn, Sypl, D12Ertd446e
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 12
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000076698
NCBIトランスクリプトID
NM_013635
ターゲット領域
Exon 3
有効領域の大きさ
~0.6 kb
遺伝子研究の概要
SYPL1, also known as synaptophysin-like 1, is a neuroendocrine-related tetratransmembrane transport vesicle protein [2,7]. It is involved in vesicle-related pathways, which are crucial for various biological processes. In the context of sperm development, it defines a vesicular pathway essential for sperm cytoplasmic droplet formation, which is important for male fertility [1]. In cancer, it has been associated with tumor-related processes, indicating its overall biological importance in both normal and disease-related biological systems. Genetic models, such as gene knockout mouse models, can be valuable for studying its functions.
Genetic ablation of SYPL1 in mice showed that it dictates the formation and accumulation of saccular elements in the forming cytoplasmic droplet of late spermatids and epididymal sperm. SYPL1 vesicles, derived from the Golgi, are critical for segregating key metabolic enzymes within the cytoplasmic droplet, which are required for sperm development and male fertility [1].
In pancreatic ductal adenocarcinoma (PDAC), gain-of-function and loss-of-function experiments demonstrated that SYPL1 promotes cell proliferation and protects cells from apoptosis. Knockdown of SYPL1 led to sustained extracellular-regulated protein kinase (ERK) activation and cell death, which was related to upregulated reactive oxygen species (ROS) [2].
In colorectal cancer, SYPL1 was upregulated at both mRNA and protein levels. Serum SYPL1 (sSYPL1) was significantly higher in CRC patients compared to controls and adenoma patients, and could distinguish CRC patients from them with high sensitivity and specificity. Fecal SYPL1 (fSYPL1) also showed high performance in distinguishing CRC patients from controls, and its level was positively correlated with tumor-related features. The levels of sSYPL1 and fSYPL1 declined significantly after radical surgery [3,4].
In hepatocellular carcinoma (HCC), SYPL1 overexpression was closely correlated with several malignant clinicopathologic features, and was identified as an independent prognostic factor for overall survival and disease-free survival. It may be associated with epithelial-mesenchymal transition (EMT) of HCC cells [5].
In oral squamous cell carcinoma (OSCC), YY1 promotes OSCC cell progression via up-regulating Kcnq1ot1 to sponge miR-506-3p and elevate SYPL1 [6].
In glioblastomas, SYPL1 was found to be upregulated in PRNPhigh/PRNP + cells, and vesicular dynamics signatures were strongly correlated with PRNP/PrPC levels where SYPL1 is involved [8].
In a study on JNK1/JNK3 interactome, SYPL1 was identified as a typical JBD-dependent interactor shared by JNK1α1 and JNK3α1 [9].
In conclusion, SYPL1 plays essential roles in multiple biological processes. In male fertility, it is crucial for sperm cytoplasmic droplet formation. In various cancers including PDAC, CRC, HCC, and OSCC, it is involved in processes such as cell proliferation, apoptosis, and metastasis, influencing cancer prognosis. The study of SYPL1 using gene knockout mouse models and other functional experiments has provided important insights into these functions, which may help in understanding the mechanisms of related diseases and developing potential therapeutic strategies.
References:
1. Liu, Jiali, Hermo, Louis, Ding, Deqiang, Hess, Rex A, Chen, Chen. 2023. SYPL1 defines a vesicular pathway essential for sperm cytoplasmic droplet formation and male fertility. In Nature communications, 14, 5113. doi:10.1038/s41467-023-40862-1. https://pubmed.ncbi.nlm.nih.gov/37607933/
2. Song, Yunda, Sun, Xuesong, Duan, Fangting, Wang, Jun, Li, Shengping. 2020. SYPL1 Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma via Suppression of ROS-Induced ERK Activation. In Frontiers in oncology, 10, 1482. doi:10.3389/fonc.2020.01482. https://pubmed.ncbi.nlm.nih.gov/33042794/
3. Liu, Lei, He, Qiao, Li, Yan, Song, Xiaoyu, Guo, Yuanbiao. 2020. Serum SYPL1 is a promising diagnostic biomarker for colorectal cancer. In Clinica chimica acta; international journal of clinical chemistry, 509, 36-42. doi:10.1016/j.cca.2020.05.048. https://pubmed.ncbi.nlm.nih.gov/32502495/
4. Shu, Tao, Wu, Kaiwen, Guo, Yuanbiao, Liu, Lei, Sun, Xiaobin. 2022. Evaluation of fecal SYPL1 as a diagnostic biomarker in colorectal cancer. In Clinical biochemistry, 103, 8-15. doi:10.1016/j.clinbiochem.2022.02.009. https://pubmed.ncbi.nlm.nih.gov/35218739/
5. Chen, Dong-Han, Wu, Qiu-Wan, Li, Xiu-Dong, Wang, Shuang-Jia, Zhang, Zhi-Ming. 2017. SYPL1 overexpression predicts poor prognosis of hepatocellular carcinoma and associates with epithelial-mesenchymal transition. In Oncology reports, 38, 1533-1542. doi:10.3892/or.2017.5843. https://pubmed.ncbi.nlm.nih.gov/28731154/
6. Ding, Yi, Duan, Heng, Lin, Jian, Zhang, Xuanxuan. 2022. YY1 accelerates oral squamous cell carcinoma progression through long non-coding RNA Kcnq1ot1/microRNA-506-3p/SYPL1 axis. In Journal of ovarian research, 15, 77. doi:10.1186/s13048-022-01000-5. https://pubmed.ncbi.nlm.nih.gov/35778739/
7. Liu, Lei, Yao, Xue, Wang, Yanrong, Liu, Jinbo, Guo, Yuanbiao. 2022. Physins in digestive system neoplasms. In Advances in clinical chemistry, 111, 157-176. doi:10.1016/bs.acc.2022.08.002. https://pubmed.ncbi.nlm.nih.gov/36427909/
8. Boccacino, Jacqueline Marcia, Dos Santos Peixoto, Rafael, Fernandes, Camila Felix de Lima, da Rocha, Edroaldo Lummertz, Lopes, Marilene Hohmuth. 2024. Integrated transcriptomics uncovers an enhanced association between the prion protein gene expression and vesicle dynamics signatures in glioblastomas. In BMC cancer, 24, 199. doi:10.1186/s12885-024-11914-6. https://pubmed.ncbi.nlm.nih.gov/38347462/
9. Chen, Wei-Kai, Yeap, Yvonne Y C, Bogoyevitch, Marie A. 2014. The JNK1/JNK3 interactome--contributions by the JNK3 unique N-terminus and JNK common docking site residues. In Biochemical and biophysical research communications, 453, 576-81. doi:10.1016/j.bbrc.2014.09.122. https://pubmed.ncbi.nlm.nih.gov/25301550/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
